Click image to enlarge
S-PLEX is MSD’s ultrasensitive assay platform. It can dramatically improve the sensitivity of immunoassays, reducing the lower limit of detection (LLOD) by 10- to 1000-fold over other assay methods. The S-PLEX NHP Tau (total) Assay has the essential components for an ultrasensitive assay that measures Tau (total) in a single-analyte format. For detailed instructions on running the Tau (total) assay, please see the product insert in the "Documentation" tab below.
Related Key Terms: Neurobiology/Neurodegeneration, Total Tau protein, Tau, MAPT, DDPAC, MTBT2, PPND, PPP1R103
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
|
Application(s)
|
|
Neurobiology/Neurodegeneration
,
Alzheimer’s Disease
|
|
|
Analyte(s)
|
|
Tau (total)
|
|
|
Species
|
|
Non-human primate
|
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600
,
SECTOR Imager 6000
,
MESO SECTOR S 600MM
,
MESO QuickPlex SQ 120
|
|
|
Plate Type
|
|
96-well
|
|
|
Capture Antibody
|
|
Mouse monoclonal
|
|
|
Detection Antibody
|
|
Mouse monoclonal
|
|
|
LLOD (Sensitivity)
|
|
37 fg/mL
|
|
|
Dynamic Range
|
|
37 - 207,000 fg/mL
|
|
|
Sample Type
|
|
Serum, Plasma, Cell Culture Supernatant
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Gene ID(s)
|
|
574327
|
|
|
UniProt ID(s)
|
|
P57786
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
S-PLEX Neurology Panel 1 (human) Calibrator Blend
|
≤-70 °C
|
1 vial
(1 vial)
|
|
|
|
S-PLEX Neurology Panel 1 (human) Coating Solution
|
≤-70 °C
|
1 vial
(1 vial)
|
|
|
|
S-PLEX Detect D2
|
≤-70 °C
|
1 each
(50 μL)
|
|
|
|
S-PLEX Detect D1
|
≤-70 °C
|
1 each
(1.7 mL)
|
|
|
|
TURBO-BOOST Human Tau Antibody
|
2-8 °C
|
1 vial
(1 plate size)
|
|
|
|
S-PLEX Multiplex, 96-Well SECTOR Plate
|
2-8 °C
|
1 each
(1 each)
|
|
|
|
|
2-8 °C
|
1 bottle
(50 mL)
|
|
|
|
Diluent 64
|
2-8 °C
|
1 bottle
(18 mL)
|
|
|
|
|
RT
|
1 bottle
(18 mL)
|
|
|
|
S-PLEX Enhance E1
|
≤-10 °C
|
1 each
(1.7 mL)
|
|
|
|
S-PLEX Enhance E2
|
≤-10 °C
|
1 vial
(1.7 mL)
|
|
|
|
S-PLEX Enhance E3
|
≤-70 °C
|
1 each
(50 μL)
|
|
|
|
|
≤-10 °C
|
1 vial
(500 μL)
|
|
|
|
Blocker S2
|
≤-10 °C
|
1 vial
(500 μL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
S-PLEX Neurology Panel 1 (human) Calibrator Blend
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
S-PLEX Neurology Panel 1 (human) Coating Solution
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
S-PLEX Detect D2
|
≤-70 °C
|
5 each
(50 μL)
|
|
|
|
S-PLEX Detect D1
|
≤-70 °C
|
5 each
(1.7 mL)
|
|
|
|
TURBO-BOOST Human Tau Antibody
|
2-8 °C
|
1 vial
(5 plate size)
|
|
|
|
S-PLEX Multiplex, 96-Well SECTOR Plate
|
2-8 °C
|
5 each
(1 each)
|
|
|
|
|
2-8 °C
|
1 bottle
(50 mL)
|
|
|
|
Diluent 64
|
2-8 °C
|
1 bottle
(90 mL)
|
|
|
|
|
RT
|
1 bottle
(90 mL)
|
|
|
|
S-PLEX Enhance E1
|
≤-10 °C
|
5 each
(1.7 mL)
|
|
|
|
S-PLEX Enhance E2
|
≤-10 °C
|
5 vial
(1.7 mL)
|
|
|
|
S-PLEX Enhance E3
|
≤-70 °C
|
5 each
(50 μL)
|
|
|
|
|
≤-10 °C
|
1 vial
(500 μL)
|
|
|
|
Blocker S2
|
≤-10 °C
|
1 vial
(500 μL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
S-PLEX Neurology Panel 1 (human) Calibrator Blend
|
≤-70 °C
|
25 vial
(1 vial)
|
|
|
|
S-PLEX Neurology Panel 1 (human) Coating Solution
|
≤-70 °C
|
25 vial
(1 vial)
|
|
|
|
S-PLEX Detect D2
|
≤-70 °C
|
25 each
(50 μL)
|
|
|
|
S-PLEX Detect D1
|
≤-70 °C
|
25 each
(1.7 mL)
|
|
|
|
TURBO-BOOST Human Tau Antibody
|
2-8 °C
|
5 vial
(5 plate size)
|
|
|
|
S-PLEX Multiplex, 96-Well SECTOR Plate
|
2-8 °C
|
25 each
(1 each)
|
|
|
|
|
2-8 °C
|
5 bottle
(50 mL)
|
|
|
|
Diluent 64
|
2-8 °C
|
5 bottle
(90 mL)
|
|
|
|
|
RT
|
5 bottle
(90 mL)
|
|
|
|
S-PLEX Enhance E1
|
≤-10 °C
|
25 each
(1.7 mL)
|
|
|
|
S-PLEX Enhance E2
|
≤-10 °C
|
25 vial
(1.7 mL)
|
|
|
|
S-PLEX Enhance E3
|
≤-70 °C
|
25 each
(50 μL)
|
|
|
|
|
≤-10 °C
|
5 vial
(500 μL)
|
|
|
|
Blocker S2
|
≤-10 °C
|
5 vial
(500 μL)
|
|
|
|
Product Inserts
|
|
|
|
Product Highlights
|
|
|
|
Certificate of analysis
|
|
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
Plasma biomarkers for diagnosis of Alzheimer’s disease and prediction of cognitive decline in individuals with mild cognitive impairment
|
|
|
|
Changes in Amyloid-β and Tau in the Cerebrospinal Fluid of Transgenic Mice Overexpressing Amyloid Precursor Protein.
|
|
|
|
High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.
|
|
|
|
Immunomodulation targeting of both Aβ and tau pathological conformers ameliorates Alzheimer's disease pathology in TgSwDI and 3xTg mouse models.
|
|
|
|
The AD-CSF-Index discriminates Alzheimer's disease patients from healthy controls: A validation study
|
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Meso Scale Japan 株式会社